Biohaven Ltd. share price logo

Biohaven Ltd.

NYSE: BHVN

Small Cap

$11.43

-0.38

(-3.26%)

as on

Biohaven Ltd. Stock Performance

as on October 14, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $11.16
    $11.79
    downward going graph

    2.36%

    Downside

    3.15%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $7.48
    $18.57
    downward going graph

    34.56%

    Downside

    62.43%

    Upside

    downward going graph

Biohaven Ltd. share price movements today

Previous Close
$11.81
Open
$11.79
Volume
2.3M
Market Cap
$1.8B
Day's Low - High
$11.16 - $11.79
52 Week Low - High
$7.48 - $18.57

Biohaven Ltd. Historical Returns

1 Month Return
-7.08 %
3 Month Return
-22.15 %
1 Year Return
-22.81 %
3 Year Return
-56.48 %
5 Year Return
-91.33 %

Biohaven Ltd. Stock Fundamentals & Key Indicators

Check Biohaven Ltd. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.8B

EPS (TTM)

-4.64

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-2.6

Industry PE ratio

-6.44

PEG Ratio

-0.05

EBITDA

-575.3M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-1328.94%

Biohaven Ltd. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Biohaven Ltd. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$1.8B-91.33%-2.600.00%0.00%
Neutral$89.8B-33.52%-28.20-12.57%0.00%
StrongBuy$129.3B179.59%29.4586.04%0.00%
Buy$76.9B39.42%17.8384.86%0.50%

Stock Returns calculator for Biohaven Ltd. Stock including INR - Dollar returns

The Biohaven Ltd. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Biohaven Ltd. investment value today

Current value as on today

₹80,271

Returns

-₹19,729

(-19.73%)

Returns from Biohaven Ltd. Stock

-₹25,294 (-25.29%)

Dollar Impact

₹5,565 (+5.57%)

Analyst Recommendation on Biohaven Ltd. Stock

Based on 8 analysts

BUY

62.50%

Buy

37.50%

Hold

0.00%

Sell

Based on 8 analysts, 62.5% of analysts recommend a 'BUY' rating for Biohaven Ltd.. Average target price of $21.27

Biohaven Ltd. Share Price Target

Get share price movements and forecasts by analysts on Biohaven Ltd..

What analysts predicted

46.26%UPSIDE

Target Price

$21.27

Current Price

$11.43

Analyzed by

8 Analysts

High

$30

Target

$21.27

Low

$10

Biohaven Ltd. target price $21.27, a slight upside of 46.26% compared to current price of $11.43. According to 8 analysts rating.

Indian Investors' Interest in Biohaven Ltd. Stock

Search interest for Biohaven Ltd. Stock has decreased by -38% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-38% versus previous 30 day period

Biohaven Ltd. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-1
0
-
-
Operating Income
-183
-333
-178
-189
-221
-211
-169
-142
-130
-124
EBITDA
-177
-317
-158
-184
-218
-195
-170
-142
-127
-134
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
1
1
1
2
2
1
3
2
2
2
Income Before Tax
-178
-319
-160
-186
-221
-197
-173
-145
-130
-136
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-179
-319
-160
-186
-221
-198
-173
-145
-130
-137
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Biohaven Ltd. Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-4
Operating Income
-
-479
-114
-218
-567
-436
-885
-745
EBITDA
-
-479
-114
-211
-568
-402
-837
-727
Interest Expense
-
-12
-
-
-
-
-
-
Depreciation
0
0
0
1
1
6
7
9
Income Before Tax
-
-528
-118
-212
-569
-409
-845
-737
Income Tax Expense
-
0
-
1
0
-1
0
1
Net Income
-
-528
-118
-213
-570
-408
-846
-738
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Biohaven Ltd. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-179
-319
-160
-186
-221
-198
-173
-145
-130
-137
Operating Cash Flow
-102
-167
-141
-170
-165
-167
-145
-130
-149
-85
Investing Cash Flow
34
-97
-93
-87
164
-15
164
-13
15
44
Financing Cash Flow
3
321
80
272
0
249
0
188
179
3
Change in Cash
-65
55
-154
14
0
66
19
44
44
-36

Biohaven Ltd. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-127
-528
-118
-213
-570
-408
-846
-738
Operating Cash Flow
-94
-377
-75
-145
-297
-331
-582
-609
Investing Cash Flow
-7
-3
-2
0
-304
129
-244
300
Financing Cash Flow
209
434
152
138
767
211
677
439
Change in Cash
107
53
73
-6
165
9
-149
130

Global Institutional Holdings in Biohaven Ltd.

Check out the Institutions with significant holdings in Biohaven Ltd..

Funds
Holdings
Michael Rockefeller
5.07%
iShares
4.21%
JANUS INVESTMENT FUND
3.32%
Vanguard
1.86%
Fidelity Select Portfolios
1.06%

Biohaven Ltd. News & Key Events

  • img

    Today's Timeline - 10 September

    Thu, 09:36 PM

    -

    Biohaven shares drop 15% after FDA imposes partial clinical hold on BHV-7000 program.

Insights on Biohaven Ltd.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 117.4% return, outperforming this stock by 173.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 699.3% return, outperforming this stock by 722.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, BHVN stock has moved down by -56.5%

About Biohaven Ltd.

Biohaven Ltd., a biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for immunology, neuroscience, and oncology therapeutic areas worldwide. It develops BHV-1300, which is in Phase 2 clinical trial to treat Graves' disease and rheumatoid arthritis; BHV-1400 that is in Phase 2 clinical trial for treating IgA nephropathy; BHV-1600, which is in Phase 1 clinical trial for the treatment of peripartum cardiomyopathy; BHV-8000 that is in Phase 3 clinical trial for treating Parkinson's disease; Opakalim, which is in Phase 3 clinical trial for the treatment of focal epilepsy; BHV-2100 that is in Phase 2 clinical trial for the treatment of pain disorders; and BHV-2000, which is in Phase 2 clinical trial for treating obesity. The company is also developing BHV-1510 that is in Phase 2 clinical trial for the treatment of advanced or metastatic epithelial tumors; and BHV-1530, which is in Phase 2 clinical trial for treating urothelial cancer and other tumors. In addition, its preclinical product pipeline includes BHV-1310 for treating myasthenia gravis; BHV-1320 for treating immune mediated-diseases; BHV-1450 for treating Pemphigus, MuSK MG, and LGI-1 Encephalitis; BHV-1420 for treating membranous nephropathy; BHV-1440 for treating Graves' disease and TED; BHV-6500 for treating type 1 diabetes; BHV-1490 for treating IgM neuropathy and Waldenstrom's; BHV-8100 for treating neurodegenerative diseases; and BHV-1955 for treating tinnitus. The company was formerly known as Biohaven Research Ltd. and changed its name to Biohaven Ltd. in September 2022. Biohaven Ltd. was incorporated in 2022 and is headquartered in New Haven, Connecticut.
OrganisationBiohaven Ltd.
Headquarters215 Church Street, New Haven, CT, 06510, US
IndustryBiotechnology
CEOVladimir Coric

Key Management of Biohaven Ltd.

Name

Title

Ms. Jennifer Porcelli

Vice President of Investor Relations

Mr. Matthew Buten

Chief Financial Officer

Ms. Deb Young

Senior Director of Regulatory Affairs & Operations

Mr. George C. Clark CPA

VP & Chief Accounting Officer

Mr. John McGill

Chief Technology Officer

Mr. Warren Volles J.D.

General Counsel & Chief Legal Officer

Mr. Clifford Bechtold M.S.

President & GM of Biohaven Ireland Chief Compliance Officer

Dr. Vladimir Coric M.D.

Chairman & CEO

Ms. Kimberly Gentile

Senior Vice President of Clinical Operations

Dr. Bruce D. Car D.V.M., DACVP, Ph.D.

Chief Innovation Officer

FAQs

What is Biohaven Ltd. share price today?

Biohaven Ltd. share price today is $11.43 as on at the close of the market. Biohaven Ltd. share today touched a day high of $11.79 and a low of $11.16.

What is the 52 week high and 52 week low for Biohaven Ltd. share?

Biohaven Ltd. share touched a 52 week high of $18.57 on and a 52 week low of $7.48 on . Biohaven Ltd. stock price today i.e. is closed at $11.43,which is 38.43% down from its 52 week high and 52.81% up from its 52 week low.

What is Biohaven Ltd.'s market capitalisation today?

Biohaven Ltd. market capitalisation is $0.00T as on .

How to invest in Biohaven Ltd. Stock (BHVN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Biohaven Ltd. on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Biohaven Ltd. Stock (BHVN) from India?

Indian investors can start investing in Biohaven Ltd. (BHVN) shares with as little as ₹95.2699966430664 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹952.70 in Biohaven Ltd. stock (as per the Rupee-Dollar exchange rate as on ). Based on Biohaven Ltd. share’s latest price of $11.43 as on October 14, 2026 at 1:29 am IST, you will get 0.8749 shares of Biohaven Ltd.. Learn more about fractional shares .

What are the returns that Biohaven Ltd. has given to Indian investors in the last 5 years?

Biohaven Ltd. stock has given -91.33% share price returns and 27.18% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?